India’s expert panel advises full approval for Covishield, Covaxin
New Delhi (Reuters) – The Indian drug regulator’s subject expert committee on Wednesday recommended full approval for Covishield and Covaxin,
Read MoreNew Delhi (Reuters) – The Indian drug regulator’s subject expert committee on Wednesday recommended full approval for Covishield and Covaxin,
Read MoreTel Aviv (Reuters) – Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is
Read MoreNew Delhi (Reuters) – India’s Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in
Read MoreBoston (AP) – Get ready to learn more Greek letters. Scientists warn that omicron’s whirlwind advance practically ensures it won’t
Read Moreby John Elder Teaching analytical thinking can reduce or protect against the adoption of conspiracy theories. The more people believe
Read MoreJakarta (Reuters) – More than 85% of Indonesia’s population has antibodies against COVID-19, a government-commissioned survey showed, but epidemiologists warned
Read MoreSeoul (Reuters) – South Korea’s ruling party presidential candidate ignited a debate this week after he proposed allowing public healthcare
Read MoreWashington (Reuters) – A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc (AZN.L), Pfizer Inc (PFE.N) and
Read MoreWashington (Reuters) – The United States reported nearly 1 million new coronavirus infections on Monday, the highest daily tally of
Read MoreCopenhagen (Reuters) – The Omicron coronavirus variant is better at circumventing vaccinated peoples’ immunity than the Delta variant, according to
Read More